Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05996185
Title Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tarsheen Sethi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.